Semisynthetic echinocandins affect cell wall deposition of Pneumocystis carinii in vitro and in vivo

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 8, 1996, Pages 1811-1816

  Bartlett, Marilyn S ^a,c   Current, William L ^b   Goheen, Michael P ^a   Boylan, Carole J ^b   Lee, Chao H ^a   Shaw, Margaret M ^a   Queener, Sherry F ^a   Smith, James W ^a  

^a INDIANA UNIVERSITY   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIDULAFUNGIN; DEXAMETHASONE; ECHINOCANDIN B DERIVATIVE; LY 307853; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CELL WALL; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG FIBROBLAST; MOUSE; NONHUMAN; PNEUMOCYSTIS CARINII; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL;

EID: 0029837527     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.8.1811     Document Type: Article

References (26)

1. +-antibody immunosuppressed mouse models of Pneumocystis carinii pneumonia for evaluation of drugs and leukocytes. Clin. Diagn. Lab. Immunol. 1: 511-516.
2. Bartlett, M. S., T. D. Edlind, C.-H. Lee, R. Dean, S. F. Queener, M. M. Shaw, and J. W. Smith. 1994. Albendazole inhibits Pneumocystis carinii proliferation in inoculated immunosuppressed mice. Antimicrob. Agents Chemother. 38:1834-1837.
3. Bartlett, M. S., J. A. Fishman, S. F. Queener, M. M. Durkin, M. A. Jay, and J. W. Smith. 1988. A new rat model of Pneumocystis carinii infection. J. Clin. Microbiol. 26:1100-1102.
4. Bartlett, M. S., S. Medley, M. Durkin, J. Piskura, and J. W. Smith. 1984 Proliferation of trophozoite forms of Pneumocystis carinii in WI-38 cell culture, abstr. 175. In Abstracts of the Annual Meeting of the American Society of Tropical Medicine and Hygiene, Washington, D.C.
5. Bartlett, M. S., S. F. Queener, M. M. Durkin, M. M. Shaw, and J. W. Smith. 1992. Inoculated mouse model of Pneumocystis carinii infection. Diagn. Microbiol. Infect. Dis. 15:129-134.
6. Bartlett, M. S., P. A. Verbanac, and J. W. Smith. 1979. Cultivation of Pneumocystis carinii with WI-38 cells. J. Clin. Microbiol. 10:796-799.
7. Boylan, C. J., and W. L. Currant. 1992. An improved rat model of Pneumocystis carinii: induced laboratory infections in Pneumocystis-free animals. Infect. Immun. 60:1588-1597.
8. Current, W. L., and C. J. Boylan. 1990. Anti-Pneumocystis activity of antifungal compounds cilofungin and echinocandin B, abstr. 858, p. 229. In Program and abstracts of the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
9. Current, W. L., J. Tang, C. Boylan, P. Watson, D. Zeckner, W. Turner, M. Rodriguez, D. Ma, and J. Radding. 1995. Glucan biosynthesis as a target for antifungals; the echinocandin class of antifungal agents, p. 143-160. In G. K. Dixon, L. G. Copping, and D. W. Hollomon (ed.), The discovery and mode of action of antifungal drugs. BIOS Scientific Publishers, Ltd., Oxford.
10. Dialynas, D. P., D. B. Wilde, P. Marrack, A. Pierres, K. A. Wall, W. Havran, G. Otten, M. R. Loken, M. Pierres, F. Kappler, and F. W. Fitch. 1983. Characterization of the murine antigenic determinant, designated L3T4a, recognized by monoclonal antibody GK1.5: expression of L3T4a by functional T cell clones appears to correlate primarily with class II MHC antigen reactivity. Immunol. Rev. 74:29-55.
11. Durkin, M. M., M. M. Shaw, M. S. Bartlett, and J. W. Smith. 1991. Culture and filtration methods for obtaining Pneumocystis carinii trophozoites and cysts. J. Protozool. 38:210S-212S.
12. Goheen, M. P., M. S. Bartlett, W. L. Current, M. M. Shaw, and J. W. Smith. 1994. Ultrastructural morphology of Pneumocystis carinii exposed to β-1-3 glucan synthase inhibitors LY302146 and LY307853, p. 282-283. In Proceedings of the 52nd Annual Meeting of the Microscopy Society of America. Microscopy Society of America, San Francisco.
13. Goheen, M. P., M. S. Bartlett, W. L. Current, M. M. Shaw, and J. W. Smith. 1994. Immuno electron microscopy of Pneumocystis carinii exposed to a β-1-3 glucan synthase inhibitor LY302146. J. Eukaryot. Microbiol. 41:89S.
14. Goheen, M. P., R. Blumershine, M. S. Bartlett, M. T. Hull, and J. W. Smith. 1992. Improved intracellular morphology of Pneumocystis carinii from rat lung by postfixation with a mixture of potassium ferrocyanine and osmium tetroxide. Biotechn. Histochem. 67:140-148.
15. Hughes, W. T., P. C. McNabb, T. D. Makres, and S. Feldman. 1974. Efficacy of trimethoprim and sulfamethoxazole in the prevention and treatment of Pneumocystis carinii pneumonitis. Antimicrob. Agents Chemother 5:289-293.
16. Hunziker, W., J. A. Whitney, and I. Mellman. 1992. Brefeldin A and the endocytic pathway. Possible implications for membrane traffic and sorting. FEBS Lett. 307:93-96.
17. Klausner, R. D., J. G. Donaldson, and J. Lippincott-Schwartz. 1992. Brefeldin A: insights into the control of membrane traffic and organelle structure. J. Cell Biol. 116:1071-1080.
18. Lee, C.-H., N. L. Bauer, M. M. Shaw, M. M. Durkin, M. S. Bartlett, S. F. Queener, and J. D. Smith. 1993. Proliferation of rat Pneumocystis carinii on cells sheeted on microcarrier beads in spinner flasks. J. Clin. Microbiol. 31: 1659-1662.
19. Masur, H. 1992. Prevention and treatment of Pneumocystis pneumonia. N. Engl. J. Med. 327:1855-1860.
20. Palluault, F., E. Dei-Cas, C. Slomianny, R. Soulez, and D. Camus. 1990. Golgi complex and lysosomes in rabbit derived Pneumocystis carinii. Biol. Cell 70:73-82.
21. Phair, J., A. Munoz, R. Detels, R. Kaslow, C. Rinaldo, and A. Saah. 1990. The risk of Pneumocystis carinii pneumonia among men infected with the human immunodeficiency virus type I. N. Engl. J. Med. 322:161-165.
22. Saah, A. J., D. R. Hoover, Y. Peng, J. P. Phair, B. Visscher, L. A. Kingsley, and L. K. Schrager. 1995. Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. JAMA 273:1197-1202.
23. Schmatz, D. M., G. Abruzzo, M. S. Powles, D. C. McFadden, J. M. Balkoovec, R. M. Black, K. Nollsstadt, and K. Bartizal. 1992. Pneumocandins from Zalerion arboricola. Biological evaluation of natural and semi-synthetic pneumocandins for activity against Pneumocystis carinii and Candida species. J. Antibiot. 45:1886-1891.
24. Schmatz, D. M., M. A. Powles, D. McFadden, K. Nollstadt, F. A. Bouffard, J. F. Dropinski, P. Liberator, and J. Anderson. 1995. New semisynthetic pneumocandins with improved efficacies against Pneumocystis carinii in the rat. Antimicrob. Agents Chemother. 39:1320-1323.
25. Schmatz, D. M., M. A. Powles, D. C. McFadden, L. Pittarelli, J. Balovec, M. Hammond, R. Zambias, P. Liberator, and J. Anderson. 1992. Antipneumocystis activity of water-soluble lipopeptide L-693,989 in rats. Antimicrob. Agents Chemother. 36:1964-1970.
26. Schmatz, D. M., M. A. Romanchek, L. A. Pittarelli, R. E. Schwartz, R. A. Fromtling, K. H. Nollstadt, F. L. Vanmiddlesworth, K. E. Wilson, and M. J. Turner. 1990. Treatment of Pneumocystis carinii pneumonia with 1,3-β-glucan synthesis inhibitors. Proc. Natl. Acad. Sci. USA 87:5950-5954.